Key result
Antihypertensive therapy improved global longitudinal strain from -17.7% to -19.6%, with improvement related to LV mass index reduction.
Why the study?
Evidence on the impact of blood pressure-lowering drugs on left ventricular mechanics in hypertension remains limited.
Does long-term antihypertensive therapy improve myocardial strain in hypertensive patients?
Meta-Analysis (n=1,140)
Does long-term antihypertensive therapy improve myocardial strain in hypertensive patients?
Antihypertensive therapy significantly improves left ventricular global longitudinal strain, an effect driven primarily by the reduction in left ventricular mass index rather than the reduction in systolic blood pressure.
Answers are grounded in this paper and cite their sources.
Supports GLS monitoring to track cardiac response to antihypertensives; extends evidence that LV mass regression drives functional gains beyond BP reduction.
AIM: Evidence on the impact of blood pressure (BP)-lowering drugs on left ventricular (LV) mechanics in hypertension is still limited. We performed a meta-analysis of speckle-tracking echocardiographic studies in order to provide a new piece of information on this topic. METHODS: The PubMed, OVID-MEDLINE, and Cochrane library databases were analysed to search for articles published from the inception up to 31 October 2021. Studies were identified by using MeSH terms and crossing the following search items: 'myocardial strain', 'left ventricular mechanics', 'speckle tracking echocardiography', 'systolic dysfunction', 'left ventricular hypertrophy', 'systemic hypertension', 'BP lowering drugs,' 'antihypertensive therapy'. RESULTS: A total of 1140 hypertensive patients (mean age 55.4 years, 50% men, follow-up 6-36 months) were included in eight studies. Pretreatment and posttreatment pooled SBP/DBPs were 148.4 ± 3.5/88.7 ± 2 vs. 127.4 ± 1.9/77.8 ± 0.9 mmHg. Corresponding values for ejection fraction (EF), LV mass (LVM) index, and global longitudinal strain (GLS) were 64 ± 2.3 vs. 65.9 ± 1.7% (SMD: 0.14 ± 0.03, CI 0.08- 0.20, P = 0.001); 108.4 ± 11.2 vs. 100.2 ± 11.0 g/m2 (SMD: -0.27 ± 0.10, CI -0.46 to -0.08, P < 0.01); -17.7 ± 0.6 vs. -19.6 ± 0.4%, (SMD 0.26 ± 0.03, CI 0.20-0.32, P < 0.0001), respectively. A meta-regression analysis showed a significant relation between GLS improvement and the extent of reduction of LVMI (P = 0.0003), but not of SBP (P = 0.27). CONCLUSION: Our meta-analysis suggests that antihypertensive treatment has a clear beneficial effect on LV mechanisms, and the improvement in GLS is mainly related to the reduction in LVMI rather than SBP.
No takes yet. Share an insight, caveat, or question.
A 2022 study conducted a meta-analysis in Hypertension (n=1,140). Antihypertensive therapy vs. Pretreatment baseline was evaluated on Global longitudinal strain (GLS) (SMD 0.26, 95% CI 0.20-0.32, p=< 0.0001). Antihypertensive therapy improved global longitudinal strain from -17.7% to -19.6%, with improvement related to LV mass index reduction.
Synapse has enriched 10 related papers. Consider them for comparative context: